Edwards Lifesciences Corporation
US ˙ NYSE ˙ US28176E1082

SecurityEW / Edwards Lifesciences Corporation
InstitutionBb&t Securities, Llc
Latest Disclosed Ownership9,700 shares
Latest Disclosed Value $ 2,134,000
Bb&t Securities, Llc reports 13.88% increase in ownership of EW / Edwards Lifesciences Corporation

On October 30, 2019 - Bb&t Securities, Llc filed a 13F-HR form disclosing ownership of 9,700 shares of Edwards Lifesciences Corporation (US:EW) valued at $711,042 USD as of September 30, 2019. The entity filed a previous 13F-HR on August 7, 2019 disclosing 8,518 shares of Edwards Lifesciences Corporation. This represents a change in shares of 13.88% during the quarter. The current value of the position is $834,200 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2019-10-30 2019-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 9,700 1,182 13.88 2,134 35.66 0.0195
2019-08-07 2019-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 8,518 -510 -5.65 1,573 -8.92 0.0143
2019-05-14 2019-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 9,028 849 10.38 1,727 37.94 0.0167
2019-02-04 2018-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 8,179 70 0.86 1,252 -11.27 0.0139
2018-11-14 2018-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 8,109 319 4.09 1,411 24.54 0.0139
2018-08-13 2018-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 7,790 324 4.34 1,133 8.84 0.0121
2018-05-14 2018-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 7,466 -4,525 -37.74 1,041 -22.95 0.0118
2018-02-15 2017-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 11,991 5,593 87.42 1,351 93.28 0.0175
2017-11-13 2017-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 6,398 -377 -5.56 699 -12.73 0.0095
2017-08-04 2017-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 6,775 -399 -5.56 801 18.84 0.0116
2017-05-11 2017-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 7,174 2,349 48.68 674 16.01 0.0092
2017-02-07 2016-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 4,825 -1,850 -27.72 581 -27.74 0.0084
2016-11-09 2016-09-30 13F * EDWARDS LIFESCIENCES COM 28176E108 6,675 868 14.95 804 39.10 0.0120
2016-08-04 2016-06-30 13F * EDWARDS LIFESCIENCES COM 28176E108 5,807 3,152 118.72 578 147.01 0.0089
2016-05-12 2016-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,655 2,655 234 0.0038
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.